|
|
01-May-2012
Afatinib shows activity in the treatment of patients with advanced lung adenocarcinoma with EGFR...
|
|
01-May-2012
Although we recorded no benefit in terms of overall survival with afatinib (which might have been...
|
|
01-May-2012
Anal HPV and anal cancer precursors were very common in MSM. However, on the basis of restricted...
|
|
01-May-2012
Celecoxib 400 mg twice daily for up to 1 year is insufficiently active in patients starting hormone...
|
|
01-May-2012
GVAX combined with 3ยท0 mg/kg ipilimumab is tolerable and safe for patients with mCRPC. Further...
|
|
01-May-2012
Our findings provide reassurance for women with hysterectomy seeking relief of climacteric symptoms...
|
|
01-May-2012
Observational studies show that regular use of aspirin reduces the long-term risk of several...
|
|
01-May-2012
Maintenance treatment with gefitinib significantly prolonged progression-free survival compared...
|
|
01-May-2012
The use of a vaccine targeting PSA that also enhances co-stimulation of the immune system did not...
|
|
01-May-2012
Ipilimumab has activity in some patients with advanced melanoma and brain metastases, particularly...
|
|
